HomeSNG • LON
add
Synairgen plc
Nakaraang pagsara
GBX 4.71
Sakop ng araw
GBX 4.37 - GBX 4.75
Sakop ng taon
GBX 3.00 - GBX 10.88
Market cap
8.93M GBP
Average na Volume
162.56K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.95M | -29.14% |
Net na kita | -1.63M | 31.28% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -1.95M | 28.75% |
Aktuwal na % ng binabayarang buwis | 10.92% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 8.59M | -19.19% |
Kabuuang asset | 10.64M | -43.12% |
Kabuuang sagutin | 1.08M | -60.69% |
Kabuuang equity | 9.56M | — |
Natitirang share | 201.37M | — |
Presyo para makapag-book | 0.94 | — |
Return on assets | -45.90% | — |
Return on capital | -51.07% | — |
Cash Flow
Net change in cash
| (GBP) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.63M | 31.28% |
Cash mula sa mga operasyon | -1.84M | 30.36% |
Cash mula sa pag-invest | 882.00K | 88,100.00% |
Cash mula sa financing | — | — |
Net change in cash | -962.50K | 63.64% |
Malayang cash flow | -1.13M | 24.89% |
Tungkol
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic. The company is developing an inhaled formulation of interferon-beta for severe viral respiratory diseases including COVID-19.
Richard Marsden was appointed chief executive officer in September 2009. Wikipedia
Itinatag
2003
Website
Mga Empleyado
36
